Onconova Therapeutics Inc Shares Near 52-Week Low - Market Mover
The shares closed 0.9% above its 52-week low of $2.28, with trading volume higher than its 30 day average
Jan 09, 2022 by Kwhen Finance Editors
Onconova Therapeutics Inc (ONTX) shares closed today at 0.9% above its 52 week low of $2.28, giving the company a market cap of $49M. The stock is currently down 9.8% year-to-date, down 75.8% over the past 12 months, and down 99.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 44.2% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Onconova Therapeutics Inc | -3.0 | -9.8 | -75.8 | -91.7 | 4.8 |
| Dow Jones Industrial Average | -0.0 | -0.3 | 18.5 | -2.0 | 23.2 |
| S&P 500 Index | -0.4 | -1.9 | 23.9 | -2.5 | 28.8 |
| Health Care | -0.7 | -5.2 | 13.2 | -5.5 | 21.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 91.8%
- The company's stock price performance over the past 12 months lags the peer average by 70.7%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Onconova Therapeutics Inc | ONTX | 0 | -9.8 | -75.8 | -91.7 | 4.8 |
| Peer Avg | N/A | 6.3 | -5.1 | -44.4 | -51.8 | 23.9 |
| Baxter International Inc. | BAX | 36.1 | 1.9 | 8.5 | -1.8 | 20.3 |
| Array Technologies Inc | ARRY | 0 | -10.0 | -72.2 | -73.6 | 9.4 |
| CTI BioPharma Corp | CTIC | -4.8 | -9.3 | -33.6 | -44.6 | 60.1 |
| Spectrum Pharmaceuticals, Inc. | SPPI | 0 | -8.7 | -68.9 | -73.6 | 4.3 |
| Cyclacel Pharmaceuticals Inc | CYCC | 0 | 0.5 | -55.9 | -65.4 | 25.4 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: